Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Nicardipine Hydrochloride Capsules, 20 mg and 30 mg, the generic version of Cardene®1 Capsules, 20 mg and 30 mg, of Chiesi USA, Inc. Glenmark’s Nicardipine Hydrochloride Capsules, 20 mg and